engages in the development, manufacture, and marketing of public access defibrillators, or automated external defibrillators (AED). The company also provides AED/cardiopulmonary resuscitation training and AED program management services.
In addition, it manufactures and markets a therapeutic in-hospital patient monitor-defibrillator that instantly and automatically treats cardiac patients with life-threatening abnormal heart rhythms without human intervention.
The company’s Powerheart G-3 Line of AEDs provides continuous monitoring capabilities before, during, and after sudden cardiac arrest, protecting the victim against delays in therapy and the reoccurrence of another life-threatening arrhythmia following resuscitation.
The Powerheart AEDs is used by educational institutions, fire and police departments, ambulances, railroads, airports, airlines, military bases, hospitals, nursing homes, health clubs, physician and dental offices, corporations, and federal, state, and local municipal agencies.
Its Powerheart Cardiac Rhythm Module is a lightweight external defibrillator that offers a complete therapeutic monitoring package, including continuous cardiac monitoring, synchronized cardioversion, noninvasive pacing, as well as manual, semiautomatic, or fully-automatic defibrillation.
Cardiac Science was formed in 1991 and is headquartered in Irvine, California.
